Skip to content
10-Q

Quarterly Report

OPKO HEALTH, INC. OPK

0001193125-26-187007

← back to feed
Filed
Apr 28, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 17, 2026 755.09M sh
Shares Diluted Q1 2026 · Mar 31, 2026 758.88M sh
Shares Diluted Q1 2026 · Mar 31, 2025 671.58M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $4.77M
Stock Repurchased Q1 2026 · Mar 31, 2025 $0
Capex Q1 2026 · Mar 31, 2026 $1.83M
Capex Q1 2026 · Mar 31, 2025 $3.19M
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$19.31M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$34.55M
Long Term Debt Q1 2026 · Mar 31, 2026 $2.01M
Long Term Debt Q1 2026 · Dec 31, 2025 $2.26M
Short Term Debt Q1 2026 · Mar 31, 2026 $1.53M
Short Term Debt Q1 2026 · Dec 31, 2025 $1.74M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $331.86M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $364.41M
Stockholders Equity Q1 2026 · Mar 31, 2026 $1.2B
Stockholders Equity Q1 2026 · Dec 31, 2025 $1.27B
Stockholders Equity Q1 2026 · Mar 31, 2025 $1.31B
Stockholders Equity Q1 2026 · Dec 31, 2024 $1.37B
Current Liabilities Q1 2026 · Mar 31, 2026 $148.38M
Current Liabilities Q1 2026 · Dec 31, 2025 $146.68M
Total Liabilities Q1 2026 · Mar 31, 2026 $652.19M
Total Liabilities Q1 2026 · Dec 31, 2025 $663.99M
Current Assets Q1 2026 · Mar 31, 2026 $535.36M
Current Assets Q1 2026 · Dec 31, 2025 $581.88M
Total Assets Q1 2026 · Mar 31, 2026 $1.86B
Total Assets Q1 2026 · Dec 31, 2025 $1.93B
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.07
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.10
Eps Basic Q1 2026 · Mar 31, 2026 −$0.07
Eps Basic Q1 2026 · Mar 31, 2025 −$0.10
Sga Expense Q1 2026 · Mar 31, 2026 $48.61M
Sga Expense Q1 2026 · Mar 31, 2025 $59.09M
Rd Expense Q1 2026 · Mar 31, 2026 $29.2M
Rd Expense Q1 2026 · Mar 31, 2025 $30.84M
Net Income Q1 2026 · Mar 31, 2026 −$54.85M
Net Income Q1 2026 · Mar 31, 2025 −$67.61M
Operating Income Q1 2026 · Mar 31, 2026 −$51.02M
Operating Income Q1 2026 · Mar 31, 2025 −$67.17M
Operating Income Q1 2026 · Sep 30, 2024 −$67.17M
Gross Profit Q1 2026 · Mar 31, 2026 $45.76M
Gross Profit Q1 2026 · Mar 31, 2025 $42.62M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $78.44M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $107.33M
Revenue Q1 2026 · Mar 31, 2026 $124.2M
Revenue Q1 2026 · Mar 31, 2025 $149.95M